Kidney Dialysis

BOSTON — Patients on kidney dialysis reported better adherence to an investigational phosphate-binding agent designed to be smaller, swallowed whole and dosed with fewer pills than available oral therapies, according to survey data.

A biotechnology company developing compatible organs for transplantation to humans, eGenesis, secured financial backing that could eventually lead to a human trial of its bioengineered pig kidney, according to a company press release.

Mohandas Narla, DSc, may hold the title of American Society of Hematology president, but his focus for the next several months will extend far beyond this country’s borders.

Outset Medical stock value took a significant downturn after the company announced in its second-quarter earnings report that it was pausing shipment of its TabloCart to obtain FDA 510(k) approval.

At the National Kidney Foundation Spring Clinical Meetings, the NKF will honor Jeanetta Wammack, RN, CDN, with the Carol Mattix Award for her work with kidney disease and patients with kidney failure.

Individuals who are not white and are receiving dialysis are more likely to report unmet existential and supportive kidney care needs than white patients, according to a research letter published in JAMA Internal Medicine.

The FDA granted accelerated approval for Calliditas Therapeutics’ drug Tarpeyo, also known as budesonide, making it the first and only FDA-approved treatment for reducing proteinuria in IgA nephropathy, according to a company press release.

Like most nephrology meetings taking place this year, the American Society of Nephrology’s annual symposia – Kidney Week – will be offered as a fully digital conference. This year’s program takes place Oct. 22-25, with early programs starting Oct. 19.